BIOMAT Database Logo BIOMAT Database Logo

Editorial: stratifying risk of adverse outcomes in cirrhosis-the Hepquant SHUNT test. Authors' reply. 2021

Sumeet K Asrani, and Gregory T Everson
Department of Hepatology and Liver Transplantation, Baylor University Medical Center, Dallas, TX, USA.

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D005402 Fistula Abnormal communication most commonly seen between two internal organs, or between an internal organ and the surface of the body. Fistulas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Sumeet K Asrani, and Gregory T Everson
Editorial: stratifying risk of adverse outcomes in cirrhosis: the Hepquant SHUNT test.
April 2021, Alimentary pharmacology & therapeutics,
Sumeet K Asrani, and Gregory T Everson
Editorial: Revisit the causes and long-term outcomes in cirrhosis patients-Authors' reply.
May 2024, Alimentary pharmacology & therapeutics,
Sumeet K Asrani, and Gregory T Everson
Editorial: neutrophil dysfunction in patients with cirrhosis--authors' reply.
October 2014, Alimentary pharmacology & therapeutics,
Sumeet K Asrani, and Gregory T Everson
Compartmental model describing the physiological basis for the HepQuant SHUNT test.
February 2023, Translational research : the journal of laboratory and clinical medicine,
Sumeet K Asrani, and Gregory T Everson
Editorial: evaluating cirrhosis progression-lessons from the heart. Authors' reply.
September 2019, Alimentary pharmacology & therapeutics,
Sumeet K Asrani, and Gregory T Everson
Editorial: when cirrhosis deserves haemodialysis-rethinking strategies. Authors' reply.
August 2019, Alimentary pharmacology & therapeutics,
Sumeet K Asrani, and Gregory T Everson
Assessing hepatic impairment in Fontan-associated liver disease using the HepQuant SHUNT test.
November 2019, Congenital heart disease,
Sumeet K Asrani, and Gregory T Everson
Ursodeoxycholic acid for adverse perinatal outcomes - Authors' reply.
March 2020, Lancet (London, England),
Sumeet K Asrani, and Gregory T Everson
Editorial: TIPSS in patients with cirrhosis and hepatocellular carcinoma - authors' reply.
January 2015, Alimentary pharmacology & therapeutics,
Sumeet K Asrani, and Gregory T Everson
Editorial: sepsis in cirrhosis - there may be trouble ahead; authors' reply.
September 2014, Alimentary pharmacology & therapeutics,
Copied contents to your clipboard!